Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Development and Testing of Novel Interventions to Improve…

U.S. National Institutes of Health·United States of America

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Closes 3/16/2027$200k – $1MGrants Notice
Get bids like this by emailBid source

Description

This notice of funding opportunity (NOFO) encourages formative research, intervention development, and pilot-testing of interventions that target HIV prevention, treatment, or services research for people who use drugs. The primary scientific areas of focus include the feasibility, tolerability, acceptability, and safety of novel or adapted interventions. Some key areas of interest include: • Behavioral, social, or structural approaches to prevent the acquisition and transmission of HIV infection • Combination biomedical and behavioral approaches to improve clinical outcomes for persons living with HIV • Interventions that address the specific needs of people who use substances The opportunity is open to a wide range of applicants, including private institutions of higher education, special district governments, native American tribal organizations, and non-profits.

Attached files

Contact

[email protected]

(301) 402-2541

Key dates

Opened
1/8/2025
Closes
3/16/2027

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
621110
Solicitation №
PAR-24-329

Budget estimate

$200,000 – $1,000,000

The budget for this grant is not explicitly stated, but based on the nature of the opportunity and the funding agency, it is likely that the award amount will be in the hundreds of thousands to millions of dollars. The National Institutes of Health is a major funding agency for medical research, and grants in this area can be substantial. Factors that may influence the likely payment range include the scope of the project, the number of applicants, and the availability of funds.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 89%

Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)

Closes 7/16/2029Opened 1/26/2026

U.S. National Institutes of Health·United States of America

89% match

HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)

Closes 9/6/2027Opened 10/1/2026

U.S. National Institutes of Health·United States of America

89% match

Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)

Closes 10/27/2027Opened 5/11/2021

U.S. National Institutes of Health·United States of America

89% match

Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)

Closes 1/7/2027Opened 9/11/2023

U.S. National Institutes of Health·United States of America

88% match

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

Closes 12/3/2027Opened 12/5/2024

U.S. National Institutes of Health·United States of America

87% match

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

Closes 3/6/2027Opened 8/2/2024

U.S. National Institutes of Health·United States of America

86% match

Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 1/8/2025

U.S. National Institutes of Health·United States of America

86% match

Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)

Closes 3/16/2029Opened 9/10/2025

U.S. National Institutes of Health·United States of America

86% match

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

Closes 3/5/2027Opened 1/17/2024

U.S. National Institutes of Health·United States of America

85% match

Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)

Closes 6/20/2029Opened 11/18/2025

U.S. National Institutes of Health·United States of America

85% match

NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

Closes 5/25/2029Opened 6/12/2025

U.S. National Institutes of Health·United States of America

85% match

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)

Closes 1/7/2027Opened 11/22/2023

U.S. National Institutes of Health·United States of America

84% match

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 5/10/2022

U.S. National Institutes of Health·United States of America

84% match

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/15/2023

U.S. National Institutes of Health·United States of America

84% match

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

Closes 11/17/2026Opened 11/22/2023

U.S. Centers for Disease Control - NCHHSTP·United States of America

84% match

Direct-to-Consumer Distribution of HIV and other STI Self-Tests

Closes 9/29/2027Opened 7/27/2026

U.S. National Institutes of Health·United States of America

84% match

NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)

Closes 3/16/2027Opened 11/3/2023

U.S. National Institutes of Health·United States of America

84% match

Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)

Closes 11/5/2027Opened 1/8/2025

U.S. National Institutes of Health·United States of America

83% match

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

Closes 12/3/2027Opened 12/5/2024

U.S. National Institutes of Health·United States of America

83% match

Implementation and Evaluation of Databases to Examine AIDS

Closes 5/26/2027Opened 5/27/2025

U.S. National Institutes of Health·United States of America

83% match

HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

Closes 2/9/2029Opened 6/4/2026

U.S. National Institutes of Health·United States of America

83% match

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

Closes 11/2/2028Opened 5/9/2025

U.S. National Institutes of Health·United States of America

83% match

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

Closes 10/28/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

83% match

LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE)

Closes 10/17/2027Opened 9/24/2026

U.S. National Institutes of Health·United States of America

83% match

Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)

Closes 1/7/2028Opened 4/1/2021